Evidence map›Paper›PMID 38756802›Full record

ArticleChemical science2024

Engineering copper plasmonic chirality

Sonia Maniappan, Camelia Dutta, Arunima Cheran, Diego M Solís, Jatish Kumar

Abstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sonia ManiappanDepartment of Chemistry Indian Institute of Science Education and Research (IISER) Tirupati Tirupati 517507 India jatish@iisertirupati.ac.in.
Camelia DuttaDepartment of Chemistry Indian Institute of Science Education and Research (IISER) Tirupati Tirupati 517507 India jatish@iisertirupati.ac.in.
Arunima CheranDepartment of Chemistry Indian Institute of Science Education and Research (IISER) Tirupati Tirupati 517507 India jatish@iisertirupati.ac.in.
Diego M SolísDepartamento de Tecnología de los Computadores y de las Comunicaciones, University of Extremadura 10003 Cáceres Spain.
Jatish KumarDepartment of Chemistry Indian Institute of Science Education and Research (IISER) Tirupati Tirupati 517507 India jatish@iisertirupati.ac.in.ORCID https://orcid.org/0000-0003-3078-6297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The formation of chiral nanosystems and their subsequent enantioselective interaction with chiral amino acids are vital steps in many biological processes. Due to their potential to mimic biological systems, the synthesis of chiral nanomaterials has garnered significant attention over the years. Despite the emergence of diverse nanomaterials showcasing strong chiral responses, the in-depth understanding of the mechanism of plasmonic chirality in copper nanoparticles and their subsequent application in various fields are least explored. Herein, we demonstrate a facile approach for the synthesis of chiral copper nanoparticles using cysteine as a chiral precursor and capping ligand. Ligand-mediated chiral induction, established through experimental findings and a theoretical model, is ascribed as the major contributor to the origin of plasmonic chirality. The enantioselective recognition of chiral copper nanoparticles towards histidine, an amino acid with vast biological functions, was meticulously investigated by leveraging the strong copper-histidine binding ability. Ligand-induced dissolution, a unique phenomenon in nanoparticle reactions, was identified as the underlying mechanism for the nanoparticle-to-complex conversion. Understanding the mechanism of chiral induction in copper nanoparticles coupled with their enantioselective recognition of biomolecules not only holds promise in biomedical research but also sheds light on their potential as catalysts for asymmetric synthesis.

Identifiers

PMID38756802
PMCPMC11095368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.